Shingles is “one of the worst pains in medicine.” A vaccine is highly effective at preventing it, but many people don’t get ...

Aussies who are classified as 'moderate to high risk' and are aged between 18 and 64 now qualify for the immunisation.

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate ...